Pancreatic Cancer Research

ResearcherUniversity of CopenhagenNo recent work listed

Jan E. Strøbech

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-9171-664X; OpenAlex author ID A5069426239. Sources: OpenAlex.

Their work

Papers
2 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
7
Papers, trials and grants by year

2021: 1 paper · 2022: none · 2023: 1 paper

Papers 2

  1. FES null mice demonstrate a reduction in neutrophil dependent pancreatic cancer metastatic burden. Co-author DOI 10.3389/fonc.2023.1096499↗
  2. Suppression of tumor-associated neutrophils by lorlatinib attenuates pancreatic cancer growth and improves treatment with immune checkpoint blockade. First author DOI 10.1038/s41467-021-23731-7↗

Closest collaborators

The 7 strongest of 7 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Janine Terra Erler · 2 shared papers, 2021–2023 · strength 0.33
  2. Sebastian Rune Nielsen · 2 shared papers, 2021–2023 · strength 0.33
  3. Chang‐Il Hwang · 1 shared paper, 2021 · strength 0.11
  4. Luís Arnes · 1 shared paper, 2021 · strength 0.11
  5. Jennifer P. Morton · 1 shared paper, 2021 · strength 0.11
  6. Owen James Sansom · 1 shared paper, 2021 · strength 0.11
  7. David Arthur Tuveson · 1 shared paper, 2021 · strength 0.11

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.